Kyowa Kirin (Japan)

117.8k citations
3.4k papers ·

Impact in

  • Physiology top 2%
    • Adenosine and Purinergic Signaling
  • Nephrology top 2%
    • Parathyroid Disorders and Treatments

Papers in

    • Bioactive Compounds and Antitumor Agents 116
    • Adenosine and Purinergic Signaling 149

Kyowa Kirin (Japan)

3.2k papers receiving 111.3k citations

Peers

Kyowa Kirin (Japan)
Comparison fields: 5 of 220
  • Physiology 5.9k
  • Nephrology 7.5k
  • Molecular Biology 60.0k
  • Toxicology 2.2k
  • Immunology 13.1k
Replace Tokyo University of Pharmacy and Life Sciences with:
Tokyo University of Pharmacy and Life Sciences Japan
University of Shizuoka Japan
National Institute of Health Sciences Japan
National Cerebral and Cardiovascular Center Japan
Keio University Hospital Japan
Kansai Medical University Japan
Takeda (Japan) Japan
Kyoto Pharmaceutical University Japan
Kirin (Japan) Japan
Japanese Foundation For Cancer Research Japan
Kyowa Kirin (Japan) relative to Tokyo University of Pharmacy and Life Sciences Japan Tokyo University of Pharmacy and Life Sciences's profile →
Citations per field
00.5×3.9×
Tokyo University of Pharmacy and Life Sciences · 1×
Citations per year

Countries citing scholars working at Kyowa Kirin (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Kyowa Kirin (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Kyowa Kirin (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyowa Kirin (Japan) more than expected).

Fields of papers published by authors at Kyowa Kirin (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Kyowa Kirin (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Kyowa Kirin (Japan) at the time of their publication.

About Kyowa Kirin (Japan)

In recent decades, authors affiliated with Kyowa Kirin (Japan) have published 3.4k papers, which have received a total of 117.8k indexed citations . Scholars at this organization have produced 119 papers in Toxicology, 161 papers in Physiology, 1.7k papers in Molecular Biology, 169 papers in Biochemistry and 352 papers in Pharmacology on the topics of Microbial Natural Products and Biosynthesis (208 papers), Monoclonal and Polyclonal Antibodies Research (193 papers), Microbial Metabolic Engineering and Bioproduction (184 papers), Glycosylation and Glycoproteins Research (165 papers), Cancer therapeutics and mechanisms (152 papers), Adenosine and Purinergic Signaling (149 papers), Bioactive Compounds and Antitumor Agents (116 papers) and Amino Acid Enzymes and Metabolism (107 papers). Their work is cited by papers focused on Physiology (5.9k citations), Nephrology (7.5k citations), Molecular Biology (60.0k citations), Toxicology (2.2k citations) and Immunology (13.1k citations). Authors at Kyowa Kirin (Japan) collaborate with scholars in Japan, Singapore and United States and have published in prestigious journals including The Journal of Antibiotics, Bioscience Biotechnology and Biochemistry, Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Biological and Pharmaceutical Bulletin. Some of Kyowa Kirin (Japan)'s most productive authors include Tatsuya Tamaoki, Hiroshi Kase, Masato Ikeda, Makoto Morimoto, Kenya Shitara, Hirofumi Nakano, ISAMI TAKAHASHI, Yuzuru Matsuda, Fusao Tomita and Mitsuo Satoh.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact